Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report) insider Todd Duchene sold 10,000 shares of the stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $26.25, for a total value of $262,500.00. Following the sale, the insider owned 2,088,895 shares of the company’s stock, valued at approximately $54,833,493.75. This represents a 0.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.
Core Scientific Trading Up 2.1%
NASDAQ CORZ traded up $0.56 during trading on Thursday, hitting $27.76. 15,417,150 shares of the company traded hands, compared to its average volume of 12,897,352. Core Scientific, Inc. has a 12 month low of $10.45 and a 12 month high of $28.19. The business has a fifty day simple moving average of $19.99 and a 200 day simple moving average of $17.89. The company has a market capitalization of $8.82 billion, a P/E ratio of -24.35 and a beta of 5.45.
Core Scientific (NASDAQ:CORZ – Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported ($1.06) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($1.04). The business had revenue of $115.24 million during the quarter, compared to the consensus estimate of $117.04 million. During the same quarter in the prior year, the business posted $1.25 EPS. Core Scientific’s quarterly revenue was up 44.9% on a year-over-year basis. Equities research analysts predict that Core Scientific, Inc. will post 0.11 EPS for the current fiscal year.
Hedge Funds Weigh In On Core Scientific
Analysts Set New Price Targets
Several equities analysts have weighed in on the company. Weiss Ratings restated a “sell (d-)” rating on shares of Core Scientific in a report on Monday, April 20th. Cantor Fitzgerald raised their target price on Core Scientific from $25.00 to $29.00 and gave the company an “overweight” rating in a report on Thursday, April 9th. Canaccord Genuity Group set a $30.00 target price on Core Scientific in a report on Friday, May 8th. BTIG Research raised their target price on Core Scientific from $23.00 to $33.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Finally, Jefferies Financial Group raised their price target on Core Scientific from $24.00 to $37.00 and gave the company a “buy” rating in a research report on Thursday, May 14th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, three have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $28.33.
Check Out Our Latest Report on Core Scientific
Core Scientific Company Profile
Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.
Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.
Further Reading
- Five stocks we like better than Core Scientific
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
